Sreeparna Lahiri

Sreeparna Lahiri currently serves as the VP of Quality, CMC at BridgeBio since February 2023. Prior experience includes multiple roles at Eidos Therapeutics from March 2019 to February 2023, where Sreeparna advanced through positions including Executive Director, QA, and Senior Director QA. Previously, Sreeparna held the title of Associate Director QA at Odonate Therapeutics™ and worked as an independent QA consultant. Notable experience also includes a Senior Quality Manager role at SanBio and QA Manager at Onyx Pharmaceuticals, an Amgen subsidiary. Educational qualifications include a Master’s degree in Regulatory Science from The Johns Hopkins University and a Master’s in Medical Biochemistry from Manipal Academy of Higher Education.